|
1
|
Agrawal V, Agrawal A, Dwivedi AN and
Tripathi K: Correlation between 2D echocardiography and
multidetector row CT for early detection of diastolic dysfunction
in normotensive diabetic patients. J Clin Diagn Res. 10:OC27–30.
2016.PubMed/NCBI
|
|
2
|
Ding Y, Wang Y, Chen J, Hu Y, Cao Z, Ren P
and Zhang Y: p21 overexpression sensitizes osteosarcoma U2OS cells
to cisplatin via evoking caspase-3 and Bax/Bcl-2 cascade. Tumour
Biol. 35:3119–3123. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pham I, Cosson E, Nguyen MT, Banu I,
Genevois I, Poignard P and Valensi P: Evidence for a specific
diabetic cardiomyopathy: An observational retrospective
echocardiographic study in 656 asymptomatic type 2 diabetic
patients. Int J Endocrinol. 7435032015.PubMed/NCBI
|
|
4
|
Zhuo C, Jiang R, Lin X and Shao M: LncRNA
H19 inhibits autophagy by epigenetically silencing of DIRAS3 in
diabetic cardiomyopathy. Oncotarget. 8:1429–1437. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Holscher ME, Bode C and Bugger H: Diabetic
Cardiomyopathy: Does the type of diabetes matter? Int J Mol Sci.
17:21362016. View Article : Google Scholar :
|
|
6
|
Xu G, Kuang G, Jiang W, Jiang R and Jiang
D: Polydatin promotes apoptosis through upregulation the ratio of
Bax/Bcl-2 and inhibits proliferation by attenuating the
beta-catenin signaling in human osteosarcoma cells. Am J Transl
Res. 8:922–931. 2016.PubMed/NCBI
|
|
7
|
Li Z, Zhang J, Mulholland M and Zhang W:
mTOR activation protects liver from ischemia/reperfusion-induced
injury through NF-kappaB pathway. FASEB J. 31:3016–3026. 2017.
View Article : Google Scholar
|
|
8
|
Korkmaz-Icöz S, Al Said S, Radovits T, Li
S, Brune M, Hegedűs P, Atmanli A, Ruppert M, Brlecic P, Lehmann LH,
et al: Oral treatment with a zinc complex of acetylsalicylic acid
prevents diabetic cardiomyopathy in a rat model of type-2 diabetes:
activation of the Akt pathway. Cardiovasc Diabetol. 15:752016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang H, Xiong Z, Wang J, Zhang S, Lei L,
Yang L and Zhang Z: Glucagon-like peptide-1 protects cardiomyocytes
from advanced oxidation protein product-induced apoptosis via the
PI3K/Akt/Bad signaling pathway. Mol Med Rep. 13:1593–1601. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He H, Qiao X and Wu S: Carbamylated
erythropoietin attenuates cardiomyopathy via PI3K/Akt activation in
rats with diabetic cardiomyopathy. Exp Ther Med. 6:567–573. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Thomas CM, Yong QC, Rosa RM, Seqqat R,
Gopal S, Casarini DE, Jones WK, Gupta S, Baker KM and Kumar R:
Cardiac-specific suppression of NF-kappaB signaling prevents
diabetic cardiomyopathy via inhibition of the renin-angiotensin
system. Am J Physiol Heart Circ Physiol. 307:H1036–1045. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang ZQ, Chen MT, Zhang R, Zhang Y, Li W
and Li YG: Docosahexaenoic acid attenuates doxorubicin-induced
cytotoxicity and inflammation by suppressing NF-kappaB/iNOS/NO
signaling pathway activation in H9C2 cardiac cells. J Cardiovasc
Pharmacol. 67:283–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ren XM, Zuo GF, Wu W, Luo J, Ye P, Chen SL
and Hu ZY: Atorvastatin alleviates experimental diabetic
cardiomyopathy by regulating the GSK-3beta-PP2Ac-NF-kappaB
signaling axis. PLoS One. 11:e01667402016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yin C, Deng Y, Gao J, Li X, Liu Y and Gong
Q: Icariside II, a novel phosphodiesterase-5 inhibitor, attenuates
streptozotocin-induced cognitive deficits in rats. Neuroscience.
328:69–79. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tian W, Lei H, Guan R, Xu Y, Li H, Wang L,
Yang B, Gao Z and Xin Z: Icariside II ameliorates diabetic
nephropathy in streptozotocin-induced diabetic rats. Drug Des Devel
Ther. 9:5147–5157. 2015.PubMed/NCBI
|
|
16
|
Frustaci A, Ciccosanti F, Chimenti C,
Nardacci R, Corazzari M, Verardo R, Ippolito G, Petrosillo N, Fimia
GM and Piacentini M: Histological and proteomic profile of diabetic
versus non-diabetic dilated cardiomyopathy. Int J Cardiol.
203:282–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu Z and Hu X: HMGB1 induced endothelial
permeability promotes myocardial fibrosis in diabetic
cardiomyopathy. Int J Cardiol. 227:8752017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lebeche D: Diabetic cardiomyopathy: is
resistin a culprit? Cardiovasc Diagn Ther. 5:387–393.
2015.PubMed/NCBI
|
|
19
|
Wu H, Sheng ZQ, Xie J, Li R, Chen L, Li
GN, Wang L and Xu B: Reduced HMGB 1-mediated pathway and oxidative
stress in resveratrol-treated diabetic mice: A possible mechanism
of cardioprotection of resveratrol in diabetes mellitus. Oxid Med
Cell Longev. 2016:98368602016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kuo WW, Wang WJ, Tsai CY, Way CL, Hsu HH
and Chen LM: Diallyl trisufide (DATS) suppresses high
glucose-induced cardiomyocyte apoptosis by inhibiting JNK/NFkappaB
signaling via attenuating ROS generation. Int J Cardiol.
168:270–280. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Varga ZV, Giricz Z, Liaudet L, Hasko G,
Ferdinandy P and Pacher P: Interplay of oxidative,
nitrosative/nitrative stress, inflammation, cell death and
autophagy in diabetic cardiomyopathy. Biochim Biophys Acta.
1852:232–242. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Suzuki H, Kayama Y, Sakamoto M, Iuchi H,
Shimizu I, Yoshino T, Katoh D, Nagoshi T, Tojo K, Minamino T, et
al: Arachidonate 12/15-lipoxygenase-induced inflammation and
oxidative stress are involved in the development of diabetic
cardiomyopathy. Diabetes. 64:618–630. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao YZ, Zhang M, Wong HL, Tian XQ, Zheng
L, Yu XC, Tian FR, Mao KL, Fan ZL, Chen PP, et al: Prevent diabetic
cardiomyopathy in diabetic rats by combined therapy of aFGF-loaded
nanoparticles and ultrasound-targeted microbubble destruction
technique. J Control Release. 223:11–21. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu W, Zha W, Guo S, Cheng H, Wu J and Liu
C: Flos Puerariae extract prevents myocardial apoptosis via
attenuation oxidative stress in streptozotocin-induced diabetic
mice. PLoS One. 9:e980442014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang L, Ding WY, Wang ZH, Tang MX, Wang
F, Li Y, Zhong M, Zhang Y and Wei Zhang: Erratum to: Early
administration of trimetazidine attenuates diabetic cardiomyopathy
in rats by alleviating fibrosis, reducing apoptosis and enhancing
autophagy. J Transl Med. 14:3092016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu MP, Zhang YS, Zhou QM, Xiong J, Dong YR
and Yan C: Higenamine protects ischemia/reperfusion induced cardiac
injury and myocyte apoptosis through activation of
beta2-AR/PI3K/AKT signaling pathway. Pharmacol Res. 104:115–123.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang J, Ji SY, Liu SZ, Jing R and Lou WJ:
Cardioprotective effect of breviscapine: Inhibition of apoptosis in
H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following
simulated ischemia/reperfusion injury. Pharmazie. 70:593–597.
2015.PubMed/NCBI
|
|
28
|
Liu W, Mao L, Ji F, Chen F, Wang S and Xie
Y: Icariside II activates EGFR-Akt-Nrf2 signaling and protects
osteoblasts from dexamethasone. Oncotarget. 8:2594–2603.
2017.PubMed/NCBI
|
|
29
|
Jiang C, Tong YL, Zhang D, Liu LZ and Wang
JF: Sinomenine prevents the development of cardiomyopathy in
diabetic rats by inhibiting inflammatory responses and blocking
activation of NF-kappaB. Gen Physiol Biophys. 36:65–74. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Song J, Feng L, Zhong R, Xia Z, Zhang L,
Cui L, Yan H, Jia X and Zhang Z: Icariside II inhibits the EMT of
NSCLC cells in inflammatory microenvironment via down-regulation of
Akt/NF-kappaB signaling pathway. Mol Carcinog. 56:36–48. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee KS, Lee HJ, Ahn KS and Kim SH, Nam D,
Kim DK, Choi DY, Ahn KS, Lu J and Kim SH:
Cyclooxygenase-2/prostaglandin E2 pathway mediates icariside II
induced apoptosis in human PC-3 prostate cancer cells. Cancer Lett.
280:93–100. 2009. View Article : Google Scholar : PubMed/NCBI
|
